PHX 2.17% 4.7¢ pharmx technologies limited

Success in the PhamX case should certainly lead to a re-rating...

  1. 285 Posts.
    lightbulb Created with Sketch. 103
    Success in the PhamX case should certainly lead to a re-rating of the SP.
    As all legal costs have been expensed, a favourable outcome will certainly improve the EBIT significantly.
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.